Costs of Managing Patients with Diabetes in a Large Health Maintenance Organization in Israel: A Retrospective Cohort Study

<b><br> </b> <p><b><</b>strong>Article full text</p> <p><br> The full text of this article can be found <a href="https://link.springer.com/article/10.1007/s13300-016-0212-9"><b>here</b>.</a><br> <br> <strong>Provide enhanced digital features for this article</strong><br> If you are an author of this publication and would like to provide additional enhanced digital features for your article then please contact <u>[email protected]</u>.<br> <br> The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.<br> <br> Other enhanced features include, but are not limited to:<br> • Slide decks<br> • Videos and animations<br> • Audio abstracts<br> • Audio slides<u></u></p> <p> </p

Mortality rates stratified by the score.

<p>For each abnormal result in admission laboratory test (urea≥43 mg/dL, sodium<136 meq/L and albumin<3.5 g/dL) one point was assigned. Patient population was stratified by the total combined score. Mortality rates presented for derivation cohort (3 hospitals, 3,941 subjects) and validation cohort (4 hospitals, 4,305 subjects).</p

Odds ratios of laboratory values for 30-day all cause mortality.

<p>Five categorized laboratory tests found to be significant in the multivariable analysis as continuous variables are presented.</p

Additional file 1: of Maccabi proactive Telecare Center for chronic conditions – the care of frail elderly patients

Appendix. Maccabi Telecare Service. (DOCX 24 kb

Calibration and Discrimination of the logistic regression models.

<p>*-adjusted for pre-hospitalization use of angiotensin-converting enzyme inhibitors, angiotensin receptors blockers, β-blockers, statins, spironolactone, digoxin and diuretics.</p><p>Laboratory tests include albumin, urea, sodium, uric acid and WBC.</p

Incidence density rate (per 1,000 person-years) of RA and OA in study cohort, by age and sex, 1998–2006.

<p>Incidence density rate (per 1,000 person-years) of RA and OA in study cohort, by age and sex, 1998–2006.</p

Proportional effects of persistence with statins on reduction of risk for RA per 10% of follow-up days covered with statins.

<p>Squares indicate adjusted HRs, horizontal lines, 95% CIs. Mutually adjusted for all covariates listed in <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000336#pmed-1000336-t004" target="_blank">Table 4</a>.</p

Study population characteristics, according to PDC with statins, patients eligible for the RA analysis (<i>n</i> = 211,627).

a<p>Kruskal-Wallis test for continuous data; χ² test for categorical data.</p>b<p>In the year prior to Index date.</p><p>GP, general practitioner; SD, standard deviation.</p

Mutually adjusted HRs and 95% CIs for OA according to PDC with statins and baseline characteristics, MHS 1998–2007.

a<p>Kruskal-Wallis test for continuous data; χ² test for categorical data.</p>b<p>In the year prior to Index date.</p><p>CVD, cardiovascular disease; GP, general practitioner.</p

Calibration plot for 30-days and 1-year mortality.

<p>Model included laboratory tests, demographics and comorbidities.</p